Global and India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Report & Forecast 2024-2034
Market Analysis and InsightsGlobal and India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market
This report focuses on global and India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market, also covers the segmentation data of other regions in regional level and county level.
The global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal and Metrics, etc. The global five biggest players hold a share of % in 2023.
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Scope and Market Size
Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
AcuraBio
Moravek
Ascendia Pharmaceuticals
Ardena
CPL
Arranta Bio
UPM Pharmaceuticals
FUJIFILM Diosynth Biotechnologies
Groupe Parima
TBD Pharmatech
Avid Bioservices
Vetter Pharma
NextPharma
Alcami
NerPharMa
Vetio
Societal CDMO
ten23 health
Piramal Pharma Solutions
MedPharm
Lundbeck
AGC Pharma Chemicals
BioVectra
Pfizer CentreOne
Jubilant Biosys
SEIKAGAKU CORPORATION
Mikart
Adare Pharma Solutions
Fermion
Samsung Biologics
Siegfried Holdings
Boehringer Ingelheim
Jubilant Pharmova Limited
Fareva SA
Segment by Type
Intermediate CDMO
API CDMO
Formulation CDMO
Protein CDMO
Gene Therapy CDMO
Cell Therapy CDMO
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
This report focuses on global and India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market, also covers the segmentation data of other regions in regional level and county level.
The global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal and Metrics, etc. The global five biggest players hold a share of % in 2023.
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Scope and Market Size
Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
By Company
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
AcuraBio
Moravek
Ascendia Pharmaceuticals
Ardena
CPL
Arranta Bio
UPM Pharmaceuticals
FUJIFILM Diosynth Biotechnologies
Groupe Parima
TBD Pharmatech
Avid Bioservices
Vetter Pharma
NextPharma
Alcami
NerPharMa
Vetio
Societal CDMO
ten23 health
Piramal Pharma Solutions
MedPharm
Lundbeck
AGC Pharma Chemicals
BioVectra
Pfizer CentreOne
Jubilant Biosys
SEIKAGAKU CORPORATION
Mikart
Adare Pharma Solutions
Fermion
Samsung Biologics
Siegfried Holdings
Boehringer Ingelheim
Jubilant Pharmova Limited
Fareva SA
Segment by Type
Intermediate CDMO
API CDMO
Formulation CDMO
Protein CDMO
Gene Therapy CDMO
Cell Therapy CDMO
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices